ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,900Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 890

$1.03M Total Retail Price of All Prescriptions

Rank: 48 out of 890

663 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

32% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 10,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,409 625 S3 1 3
SIMVASTATIN 699 352 2 5
NEXIUM 539 219 3 14
MELOXICAM 502 263 4 18
HYDROCHLOROTHIAZIDE 486 255 5 9
LEVOTHYROXINE SODIUM 471 273 6 2
OMEPRAZOLE 471 240 6 8
FUROSEMIDE 455 305 8 7
METFORMIN HCL 396 211 9 6
LISINOPRIL 366 268 10 4
POTASSIUM CHLORIDE 330 194 11 11
NABUMETONE 320 207 12 143
ATORVASTATIN CALCIUM 317 220 13 13
ALLOPURINOL 290 172 14 31
ZOLPIDEM TARTRATE 263 118 15 19
AMLODIPINE BESYLATE 256 134 16 1
METOPROLOL TARTRATE 200 146 17 15
GABAPENTIN 189 79 18 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 184 81 19 21
SYNTHROID 183 114 20 53
CRESTOR 167 99 21 25
SERTRALINE HCL 165 91 22 26
ATENOLOL 153 71 23 23
ESTRADIOL 147 116 R 24 118
PANTOPRAZOLE SODIUM 147 70 24 34
TRAMADOL HCL 141 83 26 16
ADVAIR DISKUS 140 62 27 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 132 56 28 76
CLOPIDOGREL 130 96 29 28
CLONIDINE HCL 129 95 30 35
ALENDRONATE SODIUM 129 103 30 38
ZETIA 127 105 32 81
SINGULAIR 124 47 33 79
METOPROLOL SUCCINATE 119 77 34 17
RAMIPRIL 114 41 35 80
TAMSULOSIN HCL 112 51 36 32
ACTOS 111 70 37 88
GLIMEPIRIDE 107 92 38 27
LIPITOR 106 72 39 77
CARVEDILOL 105 63 40 22
PLAVIX 102 77 41 42
NIFEDIPINE ER 102 59 41 75
CHLORZOXAZONE 102 24 R 41 341
DIOVAN HCT 101 64 44 48
PROAIR HFA 101 20 44 55
SPIRIVA 98 40 46 66
LYRICA 97 54 47 71
CYMBALTA 95 53 48 45
ENALAPRIL MALEATE 95 63 48 56
PREMARIN 94 72 R 50 105
RANITIDINE HCL 93 46 51 49
WARFARIN SODIUM 92 62 52 24
INDAPAMIDE 92 62 52 148
CYCLOBENZAPRINE HCL 88 51 R 54 64
TRAZODONE HCL 86 47 55 40
TRAMADOL HCL-ACETAMINOPHEN 86 35 55 117
LOSARTAN POTASSIUM 85 42 57 29
PHENYTOIN SODIUM EXTENDED 84 24 58 111
LOVASTATIN 83 53 59 46
FAMOTIDINE 78 42 60 90
TRICOR 77 55 61 98
DONEPEZIL HCL 74 74 62 30
ISOSORBIDE MONONITRATE ER 74 53 62 60
AMOXICILLIN 73 31 64 94
BENAZEPRIL HCL 73 30 64 44
NAMENDA 72 54 66 36
JANUVIA 71 47 67 59
ESCITALOPRAM OXALATE 70 49 68 51
OXYBUTYNIN CHLORIDE ER 70 26 68 154
DICYCLOMINE HCL 69 0 70 295
VERAPAMIL ER 68 42 71 87
ONGLYZA 68 41 71 146
LOSARTAN-HYDROCHLOROTHIAZIDE 65 31 73 57
AMITRIPTYLINE HCL 65 54 R 73 43
MECLIZINE HCL 64 42 75 97
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 52 75 122
MUPIROCIN 63 35 77 121
PRAVASTATIN SODIUM 63 55 77 10
MONTELUKAST SODIUM 62 27 79 130
LEVOFLOXACIN 62 27 79 107
BISOPROLOL FUMARATE 61 51 81 163
DIOVAN 60 47 82 33
METFORMIN HCL ER 60 51 82 54
ROPINIROLE HCL 59 50 84 93
NAPROXEN 58 38 85 84
PEN NEEDLE 57 34 86 135
VENLAFAXINE HCL ER 55 20 87 114
BUSPIRONE HCL 54 24 88 133
SYMBICORT 53 34 89 174
DILTIAZEM 24HR ER 53 45 89 149
CLOTRIMAZOLE-BETAMETHASONE 53 29 89 152
ORPHENADRINE CITRATE 52 0 R 92 372
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.